Publicaciones (21) Publicaciones de María Belén Picatoste Botija

2023

  1. Cardioprotective Effect of Empagliflozin and Circulating Ketone Bodies during Acute Myocardial Infarction

    Circulation: Cardiovascular Imaging, Vol. 16, Núm. 4, pp. E015298

  2. Protection of diabetes in aortic abdominal aneurysm: Are antidiabetics the real effectors?

    Frontiers in Cardiovascular Medicine, Vol. 10

  3. Spatiotemporal regulation of GIPR signaling impacts glucose homeostasis as revealed in studies of a common GIPR variant

    Molecular Metabolism, Vol. 78

2021

  1. Defective insulin-stimulated GLUT4 translocation in brown adipocytes induces systemic glucose homeostasis dysregulation independent of thermogenesis in female mice

    Molecular Metabolism, Vol. 53

  2. Empagliflozin Ameliorates Diastolic Dysfunction and Left Ventricular Fibrosis/Stiffness in Nondiabetic Heart Failure: A Multimodality Study

    JACC: Cardiovascular Imaging, Vol. 14, Núm. 2, pp. 393-407

2020

  1. Correlation between myocardial strain and adverse remodeling in a non-diabetic model of heart failure following empagliflozin therapy

    Expert Review of Cardiovascular Therapy, Vol. 18, Núm. 9, pp. 635-642

2019

  1. Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics

    Journal of the American College of Cardiology, Vol. 73, Núm. 15, pp. 1931-1944

2018

  1. Sitagliptin improved glucose assimilation in detriment of fatty-acid utilization in experimental type-II diabetes: Role of GLP-1 isoforms in Glut4 receptor trafficking

    Cardiovascular Diabetology, Vol. 17, Núm. 1

2016

  1. Disruption of adipose Rab10-dependent insulin signaling causes hepatic insulin resistance

    Diabetes, Vol. 65, Núm. 6, pp. 1577-1589

  2. Sphingosine-1-phosphate receptor agonist fingolimod increases myocardial salvage and decreases adverse postinfarction left ventricular remodeling in a porcine model of ischemia/reperfusion

    Circulation, Vol. 133, Núm. 10, pp. 954-966

2015

  1. Increased Stiffness Is the Major Early Abnormality in a Pig Model of Severe Aortic Stenosis and Predisposes to Congestive Heart Failure in the Absence of Systolic Dysfunction

    Journal of the American Heart Association, Vol. 4, Núm. 5

  2. Targeting metabolic disturbance in the diabetic heart

    Cardiovascular Diabetology, Vol. 14, Núm. 1

  3. Updating experimental models of diabetic cardiomyopathy

    Journal of Diabetes Research, Vol. 2015

2014

  1. Endogenous NAMPT dampens chemokine expression and apoptotic responses in stressed tubular cells

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1842, Núm. 2, pp. 293-303

  2. Pathophysiology of acute coronary syndrome

    Current Atherosclerosis Reports, Vol. 16, Núm. 4

2013

  1. Alteration of energy substrates and ROS production in diabetic cardiomyopathy

    Mediators of Inflammation, Vol. 2013

  2. Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes

    Cardiovascular Diabetology, Vol. 12, Núm. 1

  3. Sitagliptin Reduces Cardiac Apoptosis, Hypertrophy and Fibrosis Primarily by Insulin-Dependent Mechanisms in Experimental type-II Diabetes. Potential Roles of GLP-1 Isoforms

    PLoS ONE, Vol. 8, Núm. 10

2012

  1. Proteome changes in the myocardium of experimental chronic diabetes and hypertension. Role of PPARα in the associated hypertrophy

    Journal of Proteomics, Vol. 75, Núm. 6, pp. 1816-1829

2011

  1. Potential role of nuclear factor κb in diabetic cardiomyopathy

    Mediators of Inflammation, Vol. 2011